Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07279571

GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Los Angeles General Medical Center, Los Angeles, California, United States

Loading trial locations.

About this study

AIM 1: Evaluate use of an AI chatbot for HPV vaccine counseling:

PRIMARY OBJECTIVE:

I. To determine patient satisfaction with using an AI chatbot for HPV vaccine counseling.

SECONDARY OBJECTIVE:

I. To understand how patients currently obtain information about cancer care, vaccines, and artificial intelligence.

II. To describe patient experience with the AI-chatbot for vaccine counseling.

AIM 2: Increase rates of HPV vaccine uptake:

PRIMARY OBJECTIVE:

I. To evaluate if implementation of an AI chatbot for HPV vaccine counseling can affect the HPV vaccination rate of new patients served in the gynecologic oncology clinic.

OUTLINE: This is an observational study.

Patients complete a survey on study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

AI-chatbot Evaluation (Aim 1):

Inclusion criteria

  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Previously obtained the HPV vaccination (initial chatbot evaluation)
  • Eligible for HPV vaccination (pilot intervention; age <46)
  • Willing and able to provide informed consent

Exclusion criteria

  • Patients who do not speak English or Spanish
  • Patients who do not provide informed consent

HPV vaccination rate (Aim 2):

Inclusion criteria

  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Obtained the HPV vaccine

Exclusion criteria

  • None

Treatment and study plan

Non-Interventional Study

Other

Non-interventional study

Other names: Non-Interventional Observational Study, Noninterventional (Observational) Study

Primary outcomes

  1. Patient Satisfaction Scores

    Time frame: Up to 1 year

    Patients will complete a survey to assess their satisfaction with using an AI chatbot for HPV vaccine counseling.

  2. HPV Vaccination Rate

    Time frame: Up to 1 year

    HPV vaccination rate for patients who received the HPV vaccine counseling with the AI-chatbot

Secondary outcomes

  1. Demographics of patients

    Time frame: Up to 1 year

    Will be analyzed using a qualitative description of the demographics of patients involved in this specific study.

Sponsors and collaborators

Lead sponsor

University of Southern California

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Dec 12, 2025
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.